Many of you have been following us for a long time on Croblanc, and you already know that we regularly share new video content from the Youtube channel Bloomberg Markets and Finance which our community is extremely fond of. That's why we decided to make an article about it, because we are sure that you will like this new video.
To watch the video Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial that was posted today by the Youtube channel Bloomberg Markets and Finance, click on the video just above. You will then be able to discover it in streaming for free directly on our site!
For several hours, many people have been talking about this new video on social networks and it also makes people react on many discussion forums. This is not the first time that the Youtube channel Bloomberg Markets and Finance releases a video that makes people talk about it, and we know your great interest for this kind of content.
Thanks to the Internet, it's easy to talk to videographers and ask them any question you have in mind, or even give them criticism (constructive criticism, please!). If you want to give feedback to the creator of the video, feel free to contact the author by going to the "About" section of his youtube channel. Or simply try to reach him on his social networks, it's quite convenient sometimes to tweet!
We hope that you liked this video and that we were not mistaken in proposing it to you, indeed Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial is a video which interests many Internet users at the moment. We hope to see you soon on Croblanc, until then you will be able to watch other videos of Bloomberg Markets and Finance by searching a little on our dedicated platform. If you have already done the trick, go to Youtube, the content is almost infinite!
Ladies and gentlemen, we are coming to the end of this article Croblanc, we hope you have enjoyed reading it, at least as much as we have enjoyed writing it!
For your information, you can find below the description of the video Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial published by the Youtube channel Bloomberg Markets and Finance:
Moderna Inc.'s experimental personalized cancer vaccine reduced the risk of relapse or death from melanoma when combined with Merck & Co.'s Keytruda in a mid-stage trial. The combination cut the death risk or recurrence of the skin cancer by 44%. cut The drugmakers want to move into final-stage studies next year. Moderna CEO Stephane Bancel speaks with Bloomberg's Guy Johnson and Alix Steel.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en